• 제목/요약/키워드: Sinbaro3 pharmacopuncture

검색결과 5건 처리시간 0.019초

신바로3 약침과 한방치료를 병행한 견관절 관절와순 파열 환자 치험 3례 (A Case Report of Patients with Labrum Tear in Shoulder Treated by Oriental Therapy, Including Sinbaro3 Pharmacopuncture)

  • 윤태경;이소진;이은지;정주용;현민경;김문휘;박재영
    • Journal of Acupuncture Research
    • /
    • 제33권4호
    • /
    • pp.203-212
    • /
    • 2016
  • Objectives : The purpose of this report is to show that oriental therapy, using Sinbaro3 pharmacopuncture in particular, is effective for symptom improvements and ROM in patients diagnosed with labrum tear in shoulder. Methods : 3 patients were admitted to Jaseng Oriental Medicine Hospital, were diagnosed with a tear of the labrum, and were treated with oriental medicine including Sinbaro3 pharmacopuncture. 3 case were measured and assessed by SPADI(Shoulder Pain and Disability Index), shoulder range of motion (ROM) and a shoulder physical examination. Results : After treatment, patients' SPADI decreased and they showed improvement of ROM(range of movement). In patients with labrum tear, oriental medicine treatment and Sinbaro3 pharmacopuncture was effective for relieving pain and facilitating better movement. Conclusion : In line with the above results, it can considered that oriental medical therapy including Sinbaro3 pharmacopuncture is effective for the relief of pain and for recovering function in the shoulder joint.

신바로3 약침의 표준화를 위한 지표물질 검색 (Identification of Novel Standard Compounds for Standardization of Sinbaro3 Pharmacopuncture)

  • 이진호;이재웅;김민정;김은지;이인희
    • 한방재활의학과학회지
    • /
    • 제25권2호
    • /
    • pp.65-72
    • /
    • 2015
  • Objectives To investigate and validate potential standard compounds for standardization of Sinbaro3 pharmacopuncture prepared at OO Hospital of Korean Medicine. Methods Sinbaro3 pharmacopuncture was prepared by extraction, purification and hydrolysis of Harpagophytum procumbens, and various potential standard compounds were quantified through HPLC-UV and HPLC-MS analysis. Validation was examined by assessing specificity, linearity, precision, and accuracy. Results The retention time of harpagide and cinnamic acid were 15.2 min and 28.2 min, respectively, and both showed good linearity in analysis by concentration at 0.9999 and 0.9998, respectively. Intra-day variation of precision was 0.0015~0.0045% and 0.0058~0.1629%, while inter-day variation of precision was 0.0011~0.0243% and 0.0098~0.1629%, and that of accuracy was 99.53~99.89% and 99.50~99.91%, respectively. Conclusions Harpagide and cinnamic acid, which are hydrolyzates of harpagoside within Sinbaro3 pharmacopuncture, were both validated using HPLC-MS and HPLC-UV analysis, and Sinbaro3 pharmacopuncture contained 78.41 ug/ml harpagide, and 2.05 ug/ml cinnamic acid.

Treatment of Ramsay Hunt Syndrome Using Korean Medicine including Sinbaro3 Pharmacopuncture: A Case Report

  • Shin, Won Bin;Park, Ji Won;Choi, Hyo Jung;Namgoong, Jin;Kim, Sang Gyun;Min, Baek Ki
    • Journal of Acupuncture Research
    • /
    • 제36권3호
    • /
    • pp.161-165
    • /
    • 2019
  • This study was conducted to investigate whether treatment with Korean medicine might help to improve symptoms of patients diagnosed with Ramsay Hunt Syndrome. A patient diagnosed with Ramsay Hunt Syndrome was hospitalized for 15 days from October 4, 2018 to October 18, 2018 and treated using Korean medicine (Sinbaro3 pharmacopuncture, acupuncture, electroacupuncture, and herbal medicine). Therapeutic effects were evaluated using the Numerical Rating Scale (NRS), House-Brackmann grade, Yanagihara's score survey, and Digital Infrared Thermographic Imaging (DITI). After treatment, the Numerical Rating Scale score (6 at admission down to 2 points at discharge), House-Brackmann grade (Grade V down to Grade II), Yanagihara's score (6.0 up to 22.0), and Digital Infrared Thermographic Imaging showed improvement from admission to discharge. Treatment with traditional Korean medicine, may help improve symptoms of Ramsay Hunt Syndrome such as facial nerve paralysis, neuralgia after paraplegia, hearing difficulties, and dizziness.

한의학 학술지에 게재된 안면신경마비 증례 연구에서 사용된 약침에 관한 고찰 (Analysis of Pharmacopuncture Used in Facial Nerve Palsy Articles that Published in the Journal of Korean Medicine)

  • 유희조;김경준
    • 한방안이비인후피부과학회지
    • /
    • 제32권3호
    • /
    • pp.105-115
    • /
    • 2019
  • Objectives : The purpose of this study is to analyze the trends of phamacopuncture used in facial nerve palsy related articles that have been published in the Korean medicine journal. Methods : 242 papers related to facial nerve palsy were retrieved from Oriental Medicine Advanced Searching Integrated System(OASIS) and Korean Traditional Knowledge Portal(KTKP). We selected 13 research papers treated with pharmacopuncture for facial nerve palsy. We analyzed for type of pharmacopuncture used, treatment point and clinical type. Results : 1. The number of searched articles is thirteen. 2. The most common clinical type of facial nerve palsy is Bell's palsy. Other types are accompanying tympanitis type, herpes zoster oticus, caused by traumatic temporal bone fracture type, Foville syndrome, Foville-Millard-Gubler syndrome and multiple cerebral neuritis. 3. In the case of pharmacopuncture, the most frequently used type is Hominis Placenta Pharmacopunture. The second is Hwangreonhaedok-tang and Hwangreon Pharmacopuncture. Other than that BV, Sinbaro, Jungsongouhyul Pharmacopuncture, Cornu Cervi Pantotrichum Pharmacopuncture and Ginseng pharmacopuncture are used. 4. The most frequently used part as a treatment point is ST4, ST6, TE17.

신바로 약침의 SD 랫드와 비글견에 대한 단회 근육투여 독성시험 (Study on Single-dose Intramuscular Toxicity of Shinbaro Pharmacopuncture in Sprague-Dawley (SD) Rats and Beagle Dogs)

  • 이진호;정화진;이인희;이재웅;김은지;김민정
    • 한방재활의학과학회지
    • /
    • 제25권3호
    • /
    • pp.1-9
    • /
    • 2015
  • Objectives To evaluate Shinbaro Pharmacopuncture safety through analysis of potential single-dose intramuscular toxicity of Sinbaro Pharmacopucture in SD rats and Beagle dogs. Methods Single-dose intramuscular toxicity of Shinbaro Pharmacopuncture was assessed in accordance with Korea Food and Drug Administration Guidelines for toxicity testing of Medicinal Products. The SD rats were treated intramuscularly with Shinbaro Pharmacopuncture at doses of 0, 4.6, 9.2, and 18.5 mg/kg, respectively. The Beagle dogs were treated intramuscularly with Shinbaro Pharmacopuncture at doses of 2.3, and 4.6 mg/kg, respectively, and after 3 days, the procedure was repeated a second time at doses of 0.6, and 1.2 mg/kg, respectively, for toxicity testing. Mortality, change in body weight, and necropsy findings were examined for the study period. Results There were no mortalities, general symptoms, or body weight changes in the SD rats. While pyelectasis of the left kidney was observed in a male rat in the 4.6 mg/kg administration group, natural occurrence is common, and does not appear to be related with the test substance. No mortalities were observed in the Beagle dogs. In assessment of general symptoms, a female dog in the 9.2 mg/kg group displayed body weight decrease due to leftover food, but the change in body weight was within the normal range seen at 6~7 months, and the necropsy findings were not significant. The toxicity of the test substance appears to be minimal. Conclusions The results suggest that the lethal dose 50 ($LD_{50}$) and approximate lethaldose (ALD) value in single intramuscular administration of Shinbaro Pharmacopuncture in SD rats and Beagle dogs are higher than 18.5 mg/kg.